Connect with us

News

Marijuana Retail Report

Published

on

Marijuana Retail Report



89% of buyers said they would buy again at a competitive price

Exclusive data from a new, commissioned survey Swedenprovides cannabis retailers with critical information on customer behavior at the height of the critical Q4 season. Evidence shows that AI-powered digital amenities combined with expert budtender recommendations lead to a more profitable and loyal customer experience.

A survey found that 86% of cannabis consumers would be loyal to a particular dispensary if it offered personalized recommendations. Across the cannabis industry, personalized recommendations are becoming more tailored and specific thanks to advances in AI-powered retail software – such as Sweed’s all-in-one intelligent platform – that connects both shopper and shopper with useful information for each individual customer.

The survey also shows that digital convenience is very important to consumers, with 71% of customers saying they enjoy shopping with in-store kiosks and screens, such as Sweed’s new AI-powered display. Other digital tools also play an important role, as the survey found that 75% prefer easy one-click order changes, 72% want the ability to pre-order online, and 67% say delivery options are very important.

Data from the Sweed Shopper Survey gives cannabis retailers a clear picture of what to think about heading into the holiday season.

A survey commissioned by c Swedenby the leading enterprise retail technology platform for the cannabis industry, was conducted to provide cannabis retailers with valuable data to consider and implement ahead of the industry’s important shopping holiday, Green Wednesday, which has historically been one of the most profitable and competitive times in the industry. The survey found that about half, 45% of cannabis users (or about 50 million adults) plan to stock up or make special trips to the dispensary on Green Wednesday.

The survey results underscore the growing trend toward personalization-driven cannabis consumer loyalty. This trend reflects the huge leaps that dispensaries have begun to offer AI-based tools, using customer information to offer product recommendations that most accurately reflect shoppers’ interests.

Sweed is considered a pioneer in cannabis retail in combining AI-powered customer insights with effective customer interactions, using data to personalize recommendations, promotions and ultimately better inform shoppers. Sweed bridging the gap between AI tools and the trusted expertise of local developers is important as AI does not completely replace the value of expert project developers. According to survey data, cannabis retailers must offer both best-in-class digital amenities and budtender experiences to win over customers:

  • Nearly 9 in 10 (88%) cannabis consumers purchase their products through dispensaries, and the budtender experience plays a key role in shaping both purchasing choices and brand loyalty.
  • 3 out of 4 (76%) dispensary shoppers say that the experience and advice of a specialist directly influences what they buy.
    • This is especially true of Gen Z and Millennials (78%), who are more likely than older generations to rely on these recommendations (versus 73% of Gen X and Boomers).
  • About 9 out of 10 (85%) dispensary shoppers would return to the same dispensary because of the experienced dispensaries.

Building customer loyalty and increasing customer value has historically been a challenge for cannabis retailers, but Sweed’s survey shows how promotions and pricing can help dispensaries retain customers and increase their lifetime value (LTV), especially during critical shopping moments (such as Green Wednesday):

  • 89% of cannabis customers said they would be more likely to be a repeat customer if the dispensary offered competitive prices.
  • 86% said loyalty or rewards programs would also motivate repeat visits.
  • When it comes to what drives purchases, the top motivators are promotions and deals:
    • 77% report that promotions influence their choice of dispensary.
    • 78% say they are encouraged to try new brands or products.
    • 75% indicate they increase their order size during sales.
    • 79% report that discounts even change when they shop, such as shopping early or shopping around a holiday.

“Green Wednesday is one of the biggest cannabis retail moments of the year, and the results of our survey make it clear that retailers who use smarter digital tools and know how to run effective promotions will benefit the most,” said Sweed co-founder Rocco del Prioro. “At Sweed, we’re proud to lead the way with an AI-powered platform that helps dispensaries activate every step of the cannabis revenue optimization flywheel, from increasing reach and enhancing the experience to accelerating sales and driving repeat business. Our mission is to help dispensaries turn moments like Green Wednesday into real growth and long-term customer loyalty.”

Exclusive survey data was commissioned by SWEED Wired researcha trusted third-party consulting firm specializing in one-on-one surveys to study the habits and opinions of average Americans.

More information about the survey can be found at: www.sweedpos.com/resources/help-updates/blog/the-modern-cannabis-retail-roadmap-how-to-win-every-step-of-the-customer-journey.

California

Marijuana Retail Report

Published

on

By

Marijuana Retail Report

Continue Reading

Featured

Marijuana Retail Report

Published

on

By

Marijuana Retail Report



Everyone is on the edge of their seats

yesterday afternoon Washington Post and other sources report that President Trump is expected to issue an executive order directing federal agencies to reclassify marijuana as Schedule III. It’s some sexy reporting, though WaPo sources cautioned that “Trump could still change his mind” and “(a) White House official said no final decisions have been made on moving marijuana.”

That said, this is a story with legs, and I want to get back to some important points – aside from my usual refrain that marijuana shouldn’t be scheduled at all. Here are some important points to understand about a potential move to Schedule III.

Trump has options for moving marijuana

A WaPo story reports that an executive order may be in the cards. More likely – and depending on the content of the order – it will lead to a more direct, decisive approach than a formal one.”statement” and “request” released by President Biden in October 2022, which brought the redistricting process to a halt.

In August of this year, when Trump told reporters that his administration was considering moving marijuana, I laid out the following options:

  1. resume the stalled rulemaking process, adopt last year’s proposal to list marijuana in Schedule III;
  2. begin a new rulemaking process, presumably with a new proposed rule; or
  3. do away with rulemaking hearings entirely and the DOJ simply publishes a final rule listing marijuana in Schedule III (or wherever); or
  4. do nothing. Say, “We like marijuana where it’s at, science and treaties be damned.”

I noted:

One thing to address from the outset is the oft-repeated fiction that Trump could simply restore or repeal marijuana on his own via executive order. He can’t. However, he could lead the process in the same way that Biden did when Biden issued a request in 2022 that ordered HHS to review the controlled status of marijuana. Basically, Trump can say whatever he wants to see happen, and it’s likely to happen — especially given the strict loyalty the Justice Department has shown to him.

By this point, my colleague Jason Adelstone had arrived persuasive argument for the fifth option, which is that Trump could rely on Attorney General Pam Bondi to move marijuana on his own, even without rulemaking, under 21 USC § 811(d)(1). Jason concluded that “all it would take is a press release and a pen.”

Given the novelty of that approach, it is a given Prohibitionist Bondisuch a result would surprise me. In my previous post, I advocated for Option #3, which is the publication of the DOJ final rule. I explained:

Marijuana can then move to Schedule III (or wherever) within 30 or 60 days of the rules being published. Of course, people can appeal this rule. However, given the strength of the HHS findings and the apparent legal authority behind the Justice Department, it seems like an uphill battle.

I hope this is the chosen path and the administration will learn a lesson numerous, predictable errors former President Biden, DOJ Merrick Garland, and the Department of Anti-Ann Milgram when that administration made its failed foray into Schedule III.

The legal cannabis industry has benefited the most from marijuana’s transition

Schedule III was something of a holy grail for the cannabis industry, primarily because marijuana businesses would finally be taxed like other businesses. I explained:

When marijuana falls into Schedule III, the margin destruction statute, known as IRC § 280E will not apply and the cannabis industry will be changed forever. At the same time, the taxation of cannabis at the state level will not change. Or it could change for the worse if states feel emboldened to raise taxes on hemp in the absence of § 280E.

. . . .

However, I cannot stress enough that removing § 280E would change the industry forever. Having worked with cannabis companies for 13 years, I see taxation as the biggest insult to marijuana businesses – more than access to banking, intellectual property coverage, no bankruptcy, whatever. That would be HUGE.

Five things Schedule III won’t fix

We would like to remind people that Schedule III marijuana is not a one-size-fits-all solution. Here are five of the most persistent problems, in my opinion:

Criminal penalties for individuals. Possession, distribution and sale of non-FDA and non-hemp cannabis will still be criminal acts. State and local laws will not be violated in any way. We could see another 200,000 local arrestsannually, surrounded by List III.

Business headache. Like end users, state-licensed cannabis businesses would not theoretically be immune from federal prosecution. In addition, they will remain embargoed by the bankruptcy courts, will continue to fight over trademarks, and will still pay a premium for many shared services. Moreover, the intensive government regulation to which they are subject is unlikely to ease.

Banking issues. This is related to the above, and although banking it’s not the headache it used to beit still hurts. Schedule III marijuana would still be a controlled substance, and state-licensed businesses would still be “dealing” in that controlled substance, which is against federal law. Banks will continue to struggle with these dynamics.

Headache research. Contrary to popular belieffederal research won’t get any easier without significant intervention from Congress and administrations. It’s really a puzzle, but that’s our prediction.

Hemp. The industry of hop products from hemp took a big kick in the shorts last month when Congress passed PL 119-37. Most of these products will not survive the new law. The state-legal marijuana industry will benefit from less competition, and if marijuana becomes Schedule III, those operators will be less likely to lobby the hemp crowd for a “one-size-fits-all” federal hemp policy.

Schedule III Marijuana – Completion

I hope this happens and Christmas comes early for all our industry customers. However, I am cautious after viewing and to write about the rumor of carrying marijuana for most of the decade.

Source: Legal Canna Blog

Continue Reading

Canopy Growth

Marijuana Retail Report

Published

on

By

Marijuana Retail Report



MTL was founded by brothers Richard and Michel Clément from Quebec

Canopy Growth Corp. and MTL Cannabis Corp. announced that they have entered into a definitive agreement under which Canopy Growth will acquire all of the issued and outstanding common shares of MTL and settle all of the debt and debt instruments owed by MTL in a transaction valued at approximately $125 million on an all-equity basis and approximately $179 million on an enterprise value (TEV) basis.

Under the terms of the agreement, each MTL shareholder will receive a fixed consideration for each MTL share equal to: (i) 0.32 of a Canopy Growth common share (each whole share, a “Canopy Growth Share”) and (ii) $0.144 in cash.

MTL was founded by Quebec entrepreneurs and brothers Richard and Michel Clément, who built the company around a deep commitment to growing high-quality cannabis flowers. The quality of cannabis products produced through MTL’s disciplined, artisan approach to growing has earned national recognition, including being named Canada’s #1 recommended brand by enthusiasts in the Brightfield 2024 study.1. MTL provides proven operational excellence, loyal customer demand and experience in producing cannabis that works for the market. Canopy Growth intends to leverage the expertise of the MTL team as it continues to expand its line of cannabis products.

“MTL offers skilled operators, strong brands and a profitable business that will strengthen our leadership in the Canadian medical market and deepen our presence in key Canadian adult markets, including Quebec,” said Canopy Growth CEO Luc Mangeau. “Their growing experience combined with our national scale allows us to improve product quality, expand supply and accelerate our path to profitable growth. Together, we are building a stronger and more competitive Canadian business for the long term.”

“MTL was built on the idea that high-quality flowers, grown with care and consistency, will always earn the trust of consumers and patients,” said MLT Cannabis Co-Founder and Chief Cultivation Officer Richard Cleman. “Joining Canopy Growth gives us a platform to bring this philosophy to more Canadians. Our respective portfolios are very complementary and we see a great opportunity to expand MTL’s reach through Canopy Growth’s national distribution and retail relationships. We are incredibly proud of what our team has built and look forward to working with Canopy Growth to continue to elevate Canadian cannabis.”

Key transaction points are available for agreement here.

1 Recognized as Canada’s #1 Budtender Recommended Brand in the Brightfield 2024 Study, Brightfield Group, Canadian Budtender Study 2024 (in partnership with O2O). Findings based on a survey of ~670 Canadian youth in several Canadian provinces.

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media